Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Balancing diversity on panels at academic medical conferences demonstrates a commitment to the principles of diversity and inclusion. However, it seems we have a long way to go in urology, where two-thirds of sessions at major urology meetings still consist of all-male speaker panels.
Andolfi et al. report on the largest single-institution case series of robot-assisted laparoscopic pyeloplasty (RAL-P) in infants. Transitioning from RAL-P in older children to infants seems to have more to do with patient and port positioning, instrument size and intra-abdominal space than robotic surgical technique.
Biochemical recurrence following radical prostatectomy for intermediate-risk and high-risk prostate cancer is common. However, not all patients with recurrence will die from their disease. This comprehensive Review from a multidisciplinary group discusses the optimal evaluation and management of these patients to ensure balance between treatment-related morbidity and cancer control.
Conventionally fractionated external beam radiotherapy is an effective treatment for localized prostate cancer, but long treatment programmes result in a substantial burden to patients and the health-care system, which is particularly problematic in low-income and middle-income countries (LMICs) where health-care resources might be scarce and patient funds limited. Here, the authors discuss the outcomes and benefits of hypofractionation — in terms of both oncology and economics — and how it could be used to improve prostate cancer care in LMICs.
Anticholinergics are a common class of medication used in the treatment of overactive bladder. However, concerns have been raised over the potential association of anticholinergics and cognitive impairment or dementia. This Review discusses the clinical evidence and provides guidance for prescribing anticholinergics in at-risk populations.
